CXCR4 and colorectal cancer: Thus, owing to the specific CXCR4+ targeting and effective cytotoxicity of DITOX, this nanoparticle can efficiently eliminate apoptotic-resistant CXCR4+ colorectal CSCs through pyroptosis, demonstrating a promising method for colorectal cancer therapy.